Paper Review Records
全部论文审稿周期
21 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
79
天
Cost-consequence analysis of long peripheral catheters versus midline catheters: a post-hoc model-based analysis of published systematic review data
作者
Davide Giustivi; Antonio Gidaro; Marco Gemma; Stefano Elli; Daniele Privitera; Adam Fabiani展开收起
作者单位
1. Vascular Access Team ASST Lodi; 2. Department of Internal Medicine, “Luigi Sacco” Hospital, ASST-FBF-Sacco; 3. Neuroanesthesia & Intensive Care Foundation IRCCS, Neurological Institute “C. Besta”; 4. Vascular Access Team IRCCS San Gerardo dei Tintori Foundation; 5. Department of Health, Medicine and Life Sciences, Faculty of Science, Technology and Medicine, University of Luxembourg; 6. Cardiac Surgery Intensive Care Unit, Vascular Access Team, Azienda Sanitaria Universitaria Giuliano-Isontina展开收起
102
天
Comparison of 1-year costs of commercially insured patients with severe aortic stenosis undergoing surgical vs. transcatheter aortic valve replacement
作者
Suzanne J. Baron; Benjamin Z. Galper; Marcella A. Kelley; Soumya G. Chikermane; Shannon M. E. Murphy展开收起
作者单位
1. Division of Cardiology, Massachusetts General Hospital; 2. Baim Institute for Clinical Research; 3. Mid-Atlantic Permanente Medical Group; 4. Edwards LifeSciences展开收起
23
天
Uncovering the full economic impact of biosimilars: a “would have spent” counterfactual analysis of five reference biologics (infliximab, adalimumab, bevacizumab, rituximab, and trastuzumab) in the United States and Europe, 2016–2025
作者
Seungjae Yi; Minyoung Jang; Federico Di Biasio; Dongkyu Kim; Taek Sang Kwon; Jooyeop Lee; Jihyun Lee; Anja Tuomioja-Busk; Nicolas Van Gelder展开收起
作者单位
1. Market Access Celltrion, Inc; 2. Commercial, Celltrion Healthcare Italy SRL; 3. Commercial and Market Access, Celltrion Healthcare France SAS; 4. Global Marketing, Celltrion, Inc; 5. Commercial and Market Access, Celltrion Healthcare Finland; 6. Commercial and Market Access, Celltrion Healthcare Belgium展开收起
68
天
Evaluating the cost-effectiveness of enhanced cardiovascular-renal-metabolic (CVRM) screening in UK, France, Germany and Australia: a microsimulation-based enhanced CVRM screening analysis
作者
Fiona Adshead; Georgios Xydopoulos; Vasileios Vasilopoulos; Alexandre Babin; Amitava Banerjee; Bruno Detournay; Jamie Espín; Ines Hassan; Matt Kearney; Jan T. Kielstein; Koichiro Kuwahara; Nirosha Lederer; Carel W. le Roux; Natalie Raffoul; Lise Retat; Scott B. Robinson; Andrew Sindone; Juergen Wasem; Clélia-Elsa Froguel展开收起
作者单位
1. Sustainable Healthcare Coalition; 2. ZS; 3. Renaloo; 4. University College London Hospitals; 5. CEMKA; 6. Andalusian School of Public Health/Escuela Andaluza de Salud Pública (EASP); 7. CIBER en Epidemiologíay Salud Pública (CIBERESP), Spain/CIBER of Epidemiology and Public Health (CIBERESP), Spain; 8. Instituto de Investigación Biosanitaria ibs.GRANADA; 9. Praxis Health Consulting; 10. CVDACTION; 11. Universität Braunschweig; 12. Shinshu University School of Medicine; 13. Global Policy Evidence, Global Medical Evidence, Biopharmaceuticals Medical, AstraZeneca; 14. UNC Eshelman School of Pharmacy; 15. Diabetes Complications Research Centre, University College; 16. Diabetes Research Center, Ulster University; 17. National Heart Foundation; 18. Global Centre of Excellence, AstraZeneca; 19. Formerly Affiliated with ZS; 20. Concord and Ryde Hospitals, University of Sydney; 21. University Duisburg; 22. Global Policy, Advocacy and Health Equity, AstraZeneca展开收起
50
天
Real-world utilization of gonadotropins and the associated cumulative live birth rates in the United States: a retrospective claims database analysis
作者
Weiguang Xue; Emily Jungheim; Min Yang; Sanghyuk Seo; Lindsay Kelly; Wei Zhou展开收起
作者单位
1. Analysis Group, Ltd; 2. Northwestern University Feinberg School of Medicine; 3. Analysis Group, Inc; 4. Ferring Pharmaceuticals, Inc展开收起
98
天
Healthcare utilization and costs associated with dextromethorphan-bupropion versus selected other branded treatments for major depressive disorder: a US real-world study
作者
Leslie Citrome; Yang Zhao; Courtney Zeni; Nicole Princic; Megan Richards; Shawn P. Alter; Andrew J. Cutler展开收起
作者单位
1. New York Medical College; 2. Axsome Therapeutics, Inc; 3. Merative; 4. SUNY Upstate Medical University; 5. Neuroscience Education Institute展开收起
FAQ
JOURNAL OF MEDICAL ECONOMICS审稿要多久?
截至2026-11-19,CrushSCI 收录了 JOURNAL OF MEDICAL ECONOMICS 的 21 篇完整审稿记录。最快一篇从收稿到录用用了 23 天(Uncovering the full economic impact of biosimilars: a “would have spent” counterfactual analysis of five reference biologics (infliximab, adalimumab, bevacizumab, rituximab, and trastuzumab) in the United States and Europe, 2016–2025,2026-09-15 收稿,2026-10-08 录用),最慢一篇用了 114 天;平均 71.1 天,中位数 68 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
